Efficacy and safety of warfarin in patients with non-valvular atrial fibrillation and CKD G3–G5D

BACKGROUND: Observational data comparing warfarin with no treatment for patients with non-valvular atrial fibrillation (NVAF) and severely reduced glomerular filtration rate (GFR) are conflicting and randomized controlled trials (RCTs) are lacking. Most studies do not provide information on warfarin...

Descripción completa

Detalles Bibliográficos
Autores principales: Welander, Frida, Renlund, Henrik, Dimény, Emöke, Holmberg, Henrik, Själander, Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9155221/
https://www.ncbi.nlm.nih.gov/pubmed/35664263
http://dx.doi.org/10.1093/ckj/sfac022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9155221/
https://www.ncbi.nlm.nih.gov/pubmed/35664263
http://dx.doi.org/10.1093/ckj/sfac022

Ejemplares similares